Skip to main content
Erschienen in: International Urology and Nephrology 5/2012

01.10.2012 | Nephrology – Original Paper

Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center

verfasst von: Luiz Gustavo Oliveira, Juliana Luengo, Jacqueline C. T. Caramori, Augusto C. Montelli, Maria de Lourdes R. S. Cunha, Pasqual Barretti

Erschienen in: International Urology and Nephrology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Peritonitis continues to be a major cause of dropout in peritoneal dialysis (PD) patients. Changes in the prevalence of peritonitis etiologies and an increase in the frequency of methicillin-resistant coagulase-negative staphylococci (CoNS) and Gram-negative species resistant to commonly used antibiotics have been reported. As a consequence, the current clinical presentation and patient outcome may differ from classical descriptions. The objectives of this study were to describe the clinical and microbiological characteristics of PD-related peritonitis episodes that occurred over a period of 6 years at a single Brazilian dialysis center and to identify predictors of outcome.

Methods

A total of 170 peritonitis episodes that occurred in 92 PD patients between January 2004 and December 2009 were reviewed. Multivariate analysis was used to identify demographic, clinical, and microbiological factors predicting endpoints (resolution and peritonitis-related death). Patients’ characteristics and peritonitis incidence, etiology and outcomes were compared with a series of 232 episodes that occurred in the first 6 years (1995–2000) of the PD program at the same center.

Results

The overall peritonitis rate was 0.65 episodes/patient-year. Gram-positive cocci were identified in 79 (46.5%) episodes, whereas Gram-negative bacilli were isolated from 48 (28.2%). CoNS were the main Gram-positive species identified in 48 episodes. Of these, 56.3% were resistant to methicillin. Among Gram-negative species, amikacin resistance was observed in 60% of non-fermentative Gram-negative bacilli (NFGNB) and in only 3.6% of Enterobacteriaceae. The overall resolution rate was 44.1%. Oxacillin resistance and NFGNB etiology were strong predictors of non-resolution, whereas older age was the only predictor of death. Antibiotic protocols did not influence outcome. Comparison with the results obtained for the 1990–1995 period showed a lower peritonitis rate, a strong decline in the proportion of Staphylococcus aureus episodes, a significant increase in the frequency of oxacillin-resistant CoNS and amikacin-resistant NFGNB, and a significantly lower resolution and higher death rate.

Conclusions

The current clinical characteristics and outcome suggest a greater severity of peritonitis episodes and higher risk of death, possibly due to bacterial resistance. Older age is a risk factor for death.
Literatur
1.
Zurück zum Zitat Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis: The London, UK, Peritonitis Audit 2002–2003. Perit Dial Int 29:297–302PubMed Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis: The London, UK, Peritonitis Audit 2002–2003. Perit Dial Int 29:297–302PubMed
2.
Zurück zum Zitat Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F (2005) Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 25:274–284PubMed Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F (2005) Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 25:274–284PubMed
3.
Zurück zum Zitat Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P (2011) Geographic and educational factors and risk of the first peritonitis episode in Brazilian peritoneal dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 8:1944–1951CrossRef Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P (2011) Geographic and educational factors and risk of the first peritonitis episode in Brazilian peritoneal dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 8:1944–1951CrossRef
4.
Zurück zum Zitat Silva B, Hawley CM, McDonald SP, Brown FC, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 4:957–964CrossRef Silva B, Hawley CM, McDonald SP, Brown FC, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 4:957–964CrossRef
5.
Zurück zum Zitat Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PKT (2008) Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 3:91–97PubMedCrossRef Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PKT (2008) Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 3:91–97PubMedCrossRef
6.
Zurück zum Zitat Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423PubMedCrossRef Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423PubMedCrossRef
7.
Zurück zum Zitat Piraino B, Bernardini J, Florio T, Fried L (2003) Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 23:456–459PubMed Piraino B, Bernardini J, Florio T, Fried L (2003) Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 23:456–459PubMed
8.
Zurück zum Zitat Bender FH, Bernardini J, Piraino B (2006) Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 103:S44–S54PubMedCrossRef Bender FH, Bernardini J, Piraino B (2006) Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 103:S44–S54PubMedCrossRef
9.
Zurück zum Zitat Prasad N, Gupta A, Sharma RK, Prasad KN, Gulati S, Sharma AP (2003) The spectrum of bacterial peritonitis in CAPD patients in a developing country: is it different? Perit Dial Int 23:400–402PubMed Prasad N, Gupta A, Sharma RK, Prasad KN, Gulati S, Sharma AP (2003) The spectrum of bacterial peritonitis in CAPD patients in a developing country: is it different? Perit Dial Int 23:400–402PubMed
10.
Zurück zum Zitat Barretti P, Bastos KA, Dominguez J, Caramori JC (2007) Peritonitis in Latin América. Perit Dial Int 27:332–339PubMed Barretti P, Bastos KA, Dominguez J, Caramori JC (2007) Peritonitis in Latin América. Perit Dial Int 27:332–339PubMed
11.
Zurück zum Zitat Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW (2004) Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center’s experience over one decade. Perit Dial Int 24:424–432PubMed Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW (2004) Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center’s experience over one decade. Perit Dial Int 24:424–432PubMed
12.
Zurück zum Zitat Barretti P, Pereira D, Brasil MA, de Lourdes Cunha M, Caramori J, Montelli A (2009) Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center’s experience over nine years. Perit Dial Int 29:230–233PubMed Barretti P, Pereira D, Brasil MA, de Lourdes Cunha M, Caramori J, Montelli A (2009) Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center’s experience over nine years. Perit Dial Int 29:230–233PubMed
13.
Zurück zum Zitat Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B (2005) Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16:539–545PubMedCrossRef Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B (2005) Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16:539–545PubMedCrossRef
14.
Zurück zum Zitat Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S (2000) Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 20:396–411PubMed Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S (2000) Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 20:396–411PubMed
15.
Zurück zum Zitat Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA (1999) Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34:14–20PubMedCrossRef Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA (1999) Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34:14–20PubMedCrossRef
16.
Zurück zum Zitat Baker RJ, Senior H, Clemenger M, Brown EA (2003) Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 41:670–675PubMedCrossRef Baker RJ, Senior H, Clemenger M, Brown EA (2003) Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 41:670–675PubMedCrossRef
17.
Zurück zum Zitat Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, Tse KC, Lam MF, Lai KN, Lo WK (2005) Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 68:2375–2380PubMedCrossRef Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, Tse KC, Lam MF, Lai KN, Lo WK (2005) Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 68:2375–2380PubMedCrossRef
18.
Zurück zum Zitat Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F (2005) Uttley L; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25:107–131PubMed Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F (2005) Uttley L; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25:107–131PubMed
19.
Zurück zum Zitat Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18, 18th edn. CLSI, Wayne Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18, 18th edn. CLSI, Wayne
20.
Zurück zum Zitat de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, Donker AJ (1994) Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120:264–271PubMed de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, Donker AJ (1994) Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120:264–271PubMed
21.
Zurück zum Zitat Sanchez AR, Madonia C, Rascon-Pacheco RA (2008) Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Kidney Int Suppl 108:S76–S80PubMedCrossRef Sanchez AR, Madonia C, Rascon-Pacheco RA (2008) Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Kidney Int Suppl 108:S76–S80PubMedCrossRef
22.
Zurück zum Zitat Oo TN, Roberts TL, Collins AJ (2005) A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 45:372–380PubMedCrossRef Oo TN, Roberts TL, Collins AJ (2005) A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 45:372–380PubMedCrossRef
23.
Zurück zum Zitat Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV (2009) Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 4:1195–1200PubMedCrossRef Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV (2009) Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 4:1195–1200PubMedCrossRef
24.
Zurück zum Zitat Voinescu CG, Khanna R (2002) Peritonitis in peritoneal dialysis. Int J Artif Organs 25:249–260PubMed Voinescu CG, Khanna R (2002) Peritonitis in peritoneal dialysis. Int J Artif Organs 25:249–260PubMed
25.
Zurück zum Zitat Lim W, Dogra G, McDonald SP, Brown FG, Johnson DW (2011) Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int. [Epub ahead of print] Lim W, Dogra G, McDonald SP, Brown FG, Johnson DW (2011) Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int. [Epub ahead of print]
26.
Zurück zum Zitat Wiggins KJ, Johnson DW, Craig JC, Strippoli GF (2007) Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials. Am J Kidney Dis 50:967–988PubMedCrossRef Wiggins KJ, Johnson DW, Craig JC, Strippoli GF (2007) Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials. Am J Kidney Dis 50:967–988PubMedCrossRef
Metadaten
Titel
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center
verfasst von
Luiz Gustavo Oliveira
Juliana Luengo
Jacqueline C. T. Caramori
Augusto C. Montelli
Maria de Lourdes R. S. Cunha
Pasqual Barretti
Publikationsdatum
01.10.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0107-7

Weitere Artikel der Ausgabe 5/2012

International Urology and Nephrology 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.